Elevating Drug Discovery with Advanced Physiologically Relevant Human iPSC-Based
Blake Anson, PhD
Thursday, June 20th, 2019 . 12:30 – 1:00 PM
Structurally engineered human induced pluripotent stem cells (hiPSCs) enable greater physiological relevance, elevating performance in toxicity and discovery studies. StemoniX's hiPSC-derived platforms comprise neural (microBrain) or cardiac (microHeart) cells constructed with appropriate inter- and intracellular organization promoting robust activity and expected responses to known cellular modulators.